OHI vs REGN · P/E 22, rev $651.2M vs P/E 14, rev $4.29B
Omega Healthcare Investors Inc (OHI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Omega Healthcare Investors Inc (OHI) is a reit - healthcare facilities company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported OHI revenue for 2026-06-30 was $651.2M. Net income was $513.9M. OHI currently screens at market cap $13.92B and trailing P/E 21.6.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
OHI currently screens at market cap $13.92B and trailing P/E 21.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the OHI and REGN stock pages for the full models.
Not investment advice.